Dr. Bidhya Timilsina, MD

Dr. Timilsina practices at Phoenixville Hospital in Phoenixville, Pennsylvania, part of Tower Health.

Dr. Timilsina's NPI, 1083061022, was assigned on May 19, 2016. Dr. Timilsina holds Pennsylvania license MD478998.

Dr. Timilsina's primary practice is Phoenixville Hospital, at 140 Nutt Road, Phoenixville, PA 19460 in Chester County. The practice phone is (610) 983-1000.

Dr. Timilsina's primary practice is Phoenixville Hospital in Phoenixville, Pennsylvania, part of Tower Health. Dr. Timilsina is also affiliated with Reading Hospital. The medical group on file is Tower Health Medical Group. Dmand AI also links Dr. Timilsina to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Timilsina practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Timilsina's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Timilsina is licensed in Pennsylvania.

CMS data shows 1,206 Medicare services from Dr. Timilsina across 21 procedure codes in 2024, for 606 Medicare patients. Medicare paid $55,660 for them.

CMS counts 606 Medicare patients who saw Dr. Timilsina in 2024. The largest group is 65 to 74, with 265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Timilsina's median patient age at 64, with 50% women.

In 2024, Dr. Timilsina wrote 2,444 Medicare Part D claims for 362 patients. 85% of them were for generic drugs. CMS names the drug for 2,265 of them, across 29 drugs with 11 or more claims each, at $284,282 in total drug cost. In 2023, CMS named 1,238 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Timilsina for performance year 2024, reported as part of a group. Dr. Timilsina accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Timilsina, published from 2016 to 2022. 2018 was the busiest year, with 3. Dr. Timilsina has published most often in J Community Hosp Intern Med Perspect. Dr. Timilsina's most frequent co-authors are Niranjan Tachamo, MD, Saroj Lohani, MD and Salik Nazir, MD.

CMS Open Payments shows 71 general payments to Dr. Timilsina from 13 drug and device companies from 2020 to 2025. Travel and lodging make up the largest share, 61% of the total. Abbott Laboratories paid the most, $6,036.